SynthesisWiener medizinische Wochenschrift (1946)2019
[Systematic review: Validity and transferability of the results of health-economic evaluations of Transcatheter Aortic Valve Implantation].
Synthesis in Wiener medizinische Wochenschrift (1946), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimTo investigate health-economic evaluations of Transcatheter Aortic Valve Implantation (TAVI).
methodsSystematic literature search of health-economic evaluations of TAVI comparing Standard Management (Medical Management in combination with Balloon Aortic Valvuloplasty) in inoperable patients and to Surgical Aortic Valve Replacement in operable patients with intermediate/high surgical risk. Incremental cost-effectiveness ratios have been adjusted to Austrian price level (2016). The studies were evaluated according to their relevance and quality.
results15 health-economic evaluations were identified. Thereof, eight analyses were rated as sufficiently relevant and of high quality. Results showed that TAVI compared to Standard Management is cost-effective in only two out of six analyses and resulted in controversial results compared to Surgical Aortic Valve Replacement. Sensitivity analyses showed that particularly the inclusion of costs treating serious complications (i. e. stroke) or of the costs of the TAVI-procedure had significant impacts on the cost-effectiveness results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.